Related Experiment Videos
Decreased number of beta-adrenergic receptors in hypertensive vessels
Insights
Hypertension alters beta-adrenergic receptors in blood vessels, potentially contributing to the condition. Reduced receptor numbers, not affinity, were observed in hypertensive rats, suggesting a role in hypertension development.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
- Molecular Biology
Background:
- Hypertension is associated with altered responsiveness to inotropic agents.
- Beta-adrenergic receptors play a crucial role in cardiovascular regulation.
Purpose of the Study:
- To investigate the biochemical basis for altered inotropic responsiveness in hypertension.
- To determine changes in beta-adrenergic receptor number and affinity in spontaneously hypertensive rats.
Main Methods:
- Measurement of specific [3H]dihydroalprenolol binding in arterial and venous tissues.
- Assessment of isoproterenol's capacity to displace dihydroalprenolol.
Main Results:
- A significant decrease in beta-adrenergic receptor number was observed in both arteries and veins of spontaneously hypertensive rats.
- No alterations in the affinity of dihydroalprenolol for beta-adrenergic receptors were detected.
- The capacity of isoproterenol to displace dihydroalprenolol remained unchanged.
Conclusions:
- The decline in beta-adrenergic receptor number is not a consequence of elevated blood pressure.
- Reduced beta-adrenergic receptor numbers may contribute to the pathogenesis of hypertension.
Abstract:
Responsiveness to inotropic agents is altered in hypertension and may contribute to its initiation and maintenance. A biochemical basis for this change was provided by the observation that the number of beta-adrenergic receptors, as reflected in specific [3H]dihydroalprenolol binding, was diminished in both arteries and veins of spontaneously hypertensive rats. There was no change in the affinity of dihydroalprenolol for the binding sites or in the capacity of isoproterenol to displace dihydroalprenolol. The decline in beta-adrenergic receptor numbers is not secondary to blood pressure elevation but may, instead, contribute to the pathogenesis of hypertension.